The post-hoc analysis of Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE), included 1600 patients, with coronary heart disease (CHD) and a mean observation time of 3 years

To detect growth in the presence of drugs or growth inhibitors, the following susceptibility test disks from Thermo Scientific were used: Oxoid An-Ident discsincluding Erythromycin, 60 g, Rifampin, 15 g, Colistin, 10 g, Penicillin, 2 units, Kanamycin, 1000 g and Vancomycin, 5 g (R65006), Oxoid Amoxycillin Antimicrobial Susceptibility discs (11953032), Oxoid Amoxycillin/Clavulanic Acid Antimicrobial Susceptibility discs (11913812), Oxoid Azithromycin Antimicrobial Susceptibility discs (10660125), Oxoid Cefoxitin Antimicrobial Susceptibility discs (11944022), Oxoid Ciprofloxacin Antimicrobial Susceptibility discs (10351253), Oxoid Clindamycin Antimicrobial Susceptibility discs (11994012), Oxoid Doxycycline Antimicrobial Susceptibility discs (11943022), Oxoid Metronidazole Antimicrobial Susceptibility discs (11913972), Oxoid Minocycline Antimicrobial Susceptibility discs (11924002), Oxoid Moxifloxacin Antimicrobial Susceptibility discs (10431893), Oxoid Ofloxacin Antimicrobial Susceptibility discs (11912952), Oxoid Penicillin G Antimicrobial Susceptibility discs (12761760), Oxoid Spiramycin Antimicrobial Susceptibility Disks, 100 g (10451323) and Oxoid Tetracycline Antimicrobial Susceptibility discs (11963872)

This triggers a chain reaction that results in more GH being pushed into the bloodstream
My goal is simple: help you finally understand whats happening and show you there is a clear, treatable path forward